PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

acyclovir vs sofosbuvir/velpatasvir

Side-by-side comparison of acyclovir and sofosbuvir/velpatasvir Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
acyclovir Antiviral (Nucleoside Analog)
sofosbuvir/velpatasvir NS5B/NS5A Inhibitor (HCV)
Type
acyclovir Prescription
sofosbuvir/velpatasvir Prescription
Summary
acyclovir

Acyclovir is an antiviral medicine. It is used to treat infections caused by certain viruses.

sofosbuvir/velpatasvir

Vosevi is a drug that combines three medicines into one tablet. It is used to treat hepatitis C in adults who have already tried other treatments.

What It Treats
acyclovir

Acyclovir is used to treat shingles, which is caused by herpes zoster. It also treats genital herpes, both the first time you have it and when it comes back. Acyclovir can also treat chickenpox.

sofosbuvir/velpatasvir

Vosevi treats chronic hepatitis C (HCV) infection in adults. It is for those without cirrhosis or with compensated cirrhosis (Child-Pugh A). You can use it if you have genotype 1, 2, 3, 4, 5, or 6 HCV. You must have already been treated with a hepatitis C medicine containing an NS5A inhibitor, or sofosbuvir without an NS5A inhibitor (for genotypes 1a or 3).

How It Works
acyclovir

Acyclovir stops the virus from growing and spreading. It does this by interfering with the virus's ability to make copies of itself. This helps your body fight off the infection.

sofosbuvir/velpatasvir

Vosevi contains sofosbuvir, velpatasvir, and voxilaprevir. Sofosbuvir blocks a protein called NS5B polymerase that the hepatitis C virus needs to multiply. Velpatasvir blocks the NS5A protein, and voxilaprevir blocks the NS3/4A protease protein, both of which the virus also needs.

Common Side Effects
acyclovir
  • Malaise (feeling unwell)
  • Nausea
  • Diarrhea
sofosbuvir/velpatasvir
  • Headache
  • Fatigue (feeling tired)
  • Diarrhea
  • Nausea (feeling sick to your stomach)
FAERS Reports
acyclovir
  • Tiredness 7,612
  • Diarrhea 7,064
  • Using the medicine for something it's not approved for 5,797
  • Lung infection 5,474
  • Feeling sick to your stomach 5,330
sofosbuvir/velpatasvir
  • Feeling tired 2,307
  • The medicine is not working 1,928
  • Hepatitis C infection 1,734
  • Headache 1,639
  • Feeling sick to your stomach 1,386
Serious Warnings
acyclovir

Acyclovir can cause nervous system problems, especially in older adults or people with kidney problems. Tell your doctor if you have kidney problems before taking this medicine.

sofosbuvir/velpatasvir

Vosevi can cause Hepatitis B to become active again if you have had it in the past. This can cause serious liver problems, including liver failure and death. Before starting Vosevi, your doctor will test you for Hepatitis B. They will also monitor you during and after treatment.

Pregnancy
acyclovir

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if acyclovir will harm an unborn baby. Talk to your doctor about the risks and benefits of taking acyclovir while breastfeeding.

sofosbuvir/velpatasvir

It is not known if Vosevi can harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Vosevi passes into breast milk, so discuss this with your doctor if you are breastfeeding.

Also Compare — Nearby Drugs

How to Read This acyclovir vs sofosbuvir/velpatasvir Comparison

acyclovir is classified in the Antiviral (Nucleoside Analog) drug class, while sofosbuvir/velpatasvir sits within the NS5B/NS5A Inhibitor (HCV) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acyclovir has 31,277 submissions while sofosbuvir/velpatasvir has 8,994. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acyclovir and sofosbuvir/velpatasvir — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.